Literature DB >> 21825129

Synthesizing epidemiological and economic optima for control of immunizing infections.

Petra Klepac1, Ramanan Laxminarayan, Bryan T Grenfell.   

Abstract

Epidemic theory predicts that the vaccination threshold required to interrupt local transmission of an immunizing infection like measles depends only on the basic reproductive number and hence transmission rates. When the search for optimal strategies is expanded to incorporate economic constraints, the optimum for disease control in a single population is determined by relative costs of infection and control, rather than transmission rates. Adding a spatial dimension, which precludes local elimination unless it can be achieved globally, can reduce or increase optimal vaccination levels depending on the balance of costs and benefits. For weakly coupled populations, local optimal strategies agree with the global cost-effective strategy; however, asymmetries in costs can lead to divergent control optima in more strongly coupled systems--in particular, strong regional differences in costs of vaccination can preclude local elimination even when elimination is locally optimal. Under certain conditions, it is locally optimal to share vaccination resources with other populations.

Entities:  

Mesh:

Year:  2011        PMID: 21825129      PMCID: PMC3161560          DOI: 10.1073/pnas.1101694108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  A simple model for complex dynamical transitions in epidemics.

Authors:  D J Earn; P Rohani; B M Bolker; B T Grenfell
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

2.  Travelling waves and spatial hierarchies in measles epidemics.

Authors:  B T Grenfell; O N Bjørnstad; J Kappey
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

3.  Models for transmission of disease with immigration of infectives.

Authors:  F Brauer; P van den Driessche
Journal:  Math Biosci       Date:  2001-06       Impact factor: 2.144

4.  Economic evaluation of vaccination programs: the impact of herd-immunity.

Authors:  M Brisson; W J Edmunds
Journal:  Med Decis Making       Date:  2003 Jan-Feb       Impact factor: 2.583

5.  Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template.

Authors:  Jeronimo Cello; Aniko V Paul; Eckard Wimmer
Journal:  Science       Date:  2002-07-11       Impact factor: 47.728

6.  Vaccines should be kept even if polio is wiped out.

Authors:  Jeronimo Cello; Aniko V Paul; Eckard Wimmer
Journal:  Nature       Date:  2002-08-29       Impact factor: 49.962

7.  Polio endgame. Polio: The final assault?

Authors:  Leslie Roberts
Journal:  Science       Date:  2004-03-26       Impact factor: 47.728

8.  "Endgame" issues for the global polio eradication initiative.

Authors: 
Journal:  Clin Infect Dis       Date:  2001-11-19       Impact factor: 9.079

Review 9.  Measles elimination: progress and challenges.

Authors:  F T Cutts; A Henao-Restrepo; J M Olivé
Journal:  Vaccine       Date:  1999-10-29       Impact factor: 3.641

10.  Modelling vaccination strategies against foot-and-mouth disease.

Authors:  M J Keeling; M E J Woolhouse; R M May; G Davies; B T Grenfell
Journal:  Nature       Date:  2002-12-22       Impact factor: 49.962

View more
  32 in total

1.  Vacated niches, competitive release and the community ecology of pathogen eradication.

Authors:  James O Lloyd-Smith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

2.  Economic considerations for the eradication endgame.

Authors:  Scott Barrett
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

3.  Essential information: Uncertainty and optimal control of Ebola outbreaks.

Authors:  Shou-Li Li; Ottar N Bjørnstad; Matthew J Ferrari; Riley Mummah; Michael C Runge; Christopher J Fonnesbeck; Michael J Tildesley; William J M Probert; Katriona Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-15       Impact factor: 11.205

4.  Self-boosting vaccines and their implications for herd immunity.

Authors:  Nimalan Arinaminpathy; Jennie S Lavine; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

5.  Estimating drivers of autochthonous transmission of chikungunya virus in its invasion of the americas.

Authors:  T Alex Perkins; C Jessica E Metcalf; Bryan T Grenfell; Andrew J Tatem
Journal:  PLoS Curr       Date:  2015-02-10

6.  Country- and age-specific optimal allocation of dengue vaccines.

Authors:  Martial L Ndeffo Mbah; David P Durham; Jan Medlock; Alison P Galvani
Journal:  J Theor Biol       Date:  2013-10-23       Impact factor: 2.691

7.  Seven challenges in modeling vaccine preventable diseases.

Authors:  C J E Metcalf; V Andreasen; O N Bjørnstad; K Eames; W J Edmunds; S Funk; T D Hollingsworth; J Lessler; C Viboud; B T Grenfell
Journal:  Epidemics       Date:  2014-08-27       Impact factor: 4.396

8.  Optimizing reactive responses to outbreaks of immunizing infections: balancing case management and vaccination.

Authors:  Petra Klepac; Ottar N Bjørnstad; C Jessica E Metcalf; Bryan T Grenfell
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

Review 9.  Modeling infectious disease dynamics in the complex landscape of global health.

Authors:  Hans Heesterbeek; Roy M Anderson; Viggo Andreasen; Shweta Bansal; Daniela De Angelis; Chris Dye; Ken T D Eames; W John Edmunds; Simon D W Frost; Sebastian Funk; T Deirdre Hollingsworth; Thomas House; Valerie Isham; Petra Klepac; Justin Lessler; James O Lloyd-Smith; C Jessica E Metcalf; Denis Mollison; Lorenzo Pellis; Juliet R C Pulliam; Mick G Roberts; Cecile Viboud
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

10.  Comparative performance of between-population vaccine allocation strategies with applications to SARS-CoV-2.

Authors:  Keya Joshi; Eva Rumpler; Lee Kennedy-Shaffer; Rafia Bosan; Marc Lipsitch
Journal:  medRxiv       Date:  2022-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.